U.S. markets closed

Novartis AG (NVS)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
76.01-1.13 (-1.46%)
At close: 04:00PM EDT
76.34 +0.33 (+0.43%)
After hours: 06:56PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Short-term KST

Short-term KST

Previous Close77.14
Bid75.21 x 1300
Ask77.90 x 900
Day's Range75.53 - 76.62
52 Week Range75.53 - 94.26
Avg. Volume2,150,422
Market Cap166.305B
Beta (5Y Monthly)0.49
PE Ratio (TTM)7.45
EPS (TTM)10.20
Earnings DateN/A
Forward Dividend & Yield3.33 (4.37%)
Ex-Dividend DateMar 08, 2022
1y Target Est102.00
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
Near Fair Value
3% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for NVS

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Novartis AG
    Analyst Report: Novartis AGNovartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
    Fair Value
    Economic Moat
    3 days agoMorningstar
View more